CMS has already delayed Medicaid managed care once, pushing the start date back to at least March 1, 2016.
If you thought the high-stakes politics in Iowa ended with last week’s caucuses, think again.
The yearlong battle over whether the state’s 560,000 Medicaid beneficiaries will all moved into managed care continues unabated, and the Democrats who have long opposed the move aren’t letting up.
On Monday, two state Senate committees voted on a bill to block Republican Governor Terry Branstad from moving forward with his plan, which he said would save Iowa $51 million in its first 6 months when first proposed. But that was before delays from CMS and lawsuits from spurned contractors. While the bill has symbolic importance, it is not expected to move forward in the Republican-controlled Iowa House.
Branstad’s plan scheduled to proceed January 1, 2016, but CMS found the state was not ready to proceed and delayed the changeover until at least March 1, 2016. In the interim, the Des Moines Register produced documents that show saving estimates were later revised downward to $36.6 million.
Now the stakes are getting even higher. During Monday’s voting, a Republican senator joined Democrats in calling for a delay. Branstad’s predecessor, Democratic former Governor Chet Culver is holding his own town meetings on what opponents are calling Medicaid “privatization.” And the state’s lone Democratic Congressman is making the case to no less than President Obama himself.
US Representative Dave Loebsack released a letter dated Monday, which reads in part, “I have spoken personally to many Iowans who would be impacted by this change, including the parents of children with disabilities. Each these parents are scared that their children will not be able to access the life-sustaining therapies the need once the transition is made. …”
“These parents are not getting the answers they need,” the letter states.
At each step, Branstad has responded to critics by saying that Medicaid spending at current levels was not sustainable, and that a change to managed care was needed to deliver better coordinated care into the future. He especially took issue with Culver’s emergence in the debate, saying that the Democrat spent $440 million in one-time revenues on Medicaid, which Branstad said “dug a big hole” that had to be fixed.
Branstad told the Register, “For (Culver) to now join with the Senate Democrats to try to torpedo a thoughtful, systematic approach to modernize Medicaid to improve the health of Iowans and to better coordinate care, something that has already been done in big states controlled by Democrats like New York and California, I think is outrageous.”
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Survival Rates in CLL: Targeted Agents vs Fludarabine Combo Therapy Study
April 17th 2024Researchers conducted an analysis of 4 phase 3 trials, covering 2751 patients, to address the potential for targeted agents in younger and physically fit patients who have chronic lymphocytic leukemia (CLL).
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Study Links COVID-19 Pandemic to Rise in Neoadjuvant Chemotherapy for Ovarian Cancer in US
April 17th 2024There was greater use of neoadjuvant chemotherapy among US patients with ovarian cancer (OC) during the COVID-19 pandemic to reduce potential COVID-19 exposure and cancer treatment-related complications.
Read More